Latest 杨贵妃传媒視頻 Health News Stories
How a Duty To Spend Wisely on Worker Benefits Could Loosen PBMs鈥 Grip on Drug Prices
As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the 鈥淏ig Three鈥 PBMs 鈥 or force them to change.
Florida鈥檚 Canada Drug Importation Plan Has Yet to Launch
Florida Gov. Ron DeSantis (R) spent years complaining that the Biden administration was slow-walking federal approval of his plan to import lower-cost prescription drugs from Canada 鈥 a concept endorsed by Donald Trump in 2020 just before his first presidential term ended. But nearly a year since the Food and Drug Administration green-lit the state鈥檚 […]
Florida Gov. DeSantis鈥 Canadian Drug Import Plan Goes Nowhere After FDA Approval
Florida sued the FDA over what it said was a 鈥渞eckless delay鈥 in approving its drug importation plan. Now, nearly a year after the FDA gave the state the green light, the program has yet to begin.
El plan del gobernador de Florida para importar medicamentos m谩s baratos de Canad谩 sigue en la nada
Florida solicit贸 crear un programa de importaci贸n en noviembre de 2020, pocos meses despu茅s que la administraci贸n Trump concediera esta opci贸n a los estados.
What鈥檚 at Stake: A Pivotal Election for Six Big Health Issues
Health care has ebbed and surged as an election issue throughout the presidential campaign. Here are the ways some of the most consequential changes in health policies could hinge on whether Vice President Kamala Harris or former President Donald Trump wins.
What the Health? From 杨贵妃传媒視頻 Health News: Less Than Two Weeks To Go
With Election Day rapidly approaching, abortion is gaining traction as a voting issue, according to public opinion polls. Meanwhile, states with abortion bans are reviving the lawsuit 鈥 dismissed by the Supreme Court on a technicality this year 鈥 that could roll back the availability of the abortion pill mifepristone. Sarah Karlin-Smith of the Pink Sheet, Rachel Cohrs Zhang of Stat, and Victoria Knight of Axios join 杨贵妃传媒視頻 Health News鈥 Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Tricia Neuman, senior vice president of KFF and executive director of its Program on Medicare Policy, about Medicare open enrollment and the changes to the federal program for 2025.
PBM Math: Big Chains Are Paid $23.55 To Fill a Blood Pressure Rx. Small Drugstores? $1.51.
Criticism of prescription drug middlemen has intensified recently in the wake of a federal agency鈥檚 actions and legislative reform attempts. Georgia Republican Gov. Brian Kemp, though, vetoed a related bill that would have helped independent pharmacies, citing the unfunded cost of the move.
Beneficiarios de Medicare gastar谩n menos en medicamentos en 2025
El per铆odo de inscripci贸n anual para que los beneficiarios de Medicare renueven o cambien su cobertura de medicamentos, o elijan un plan Medicare Advantage, comenz贸 el 15 de octubre y se extiende hasta el 7 de diciembre.
Medicare Drug Plans Are Getting Better Next Year. Some Will Also Cost More.
Every year, Medicare officials encourage beneficiaries to shop around for their drug coverage. Few take the time. This year, it might be more important than ever.
What the Health? From 杨贵妃传媒視頻 Health News: Yet Another Promise for Long-Term Care Coverage
As part of her presidential campaign, Vice President Kamala Harris has rolled out a plan for Medicare to provide in-home long-term care services. The proposal would fill a longtime need for families trying to simultaneously care for young children and older parents, but its enormous price tag makes it a promise unlikely to be fulfilled. Meanwhile, a growing number of Republican candidates up and down the ballot facing voter backlash over their support for abortion restrictions are trying to reinvent their positions. Shefali Luthra of The 19th, Jessie Hellmann of CQ Roll Call, and Joanne Kenen of Johns Hopkins University and Politico join 杨贵妃传媒視頻 Health News鈥 Julie Rovner to discuss these stories and more. Also this week, excerpts from a KFF lunch with 鈥淪hark Tank鈥 panelist and generic drug discounter Mark Cuban, who has been consulting with the Harris campaign about health care issues.
Employers Haven鈥檛 a Clue How Their Drug Benefits Are Managed
The Big Three pharmacy benefit managers say they return nearly all the rebates they get from drugmakers to the employers and insurers who hire them. But most employers seem to doubt that.
What the Health? From 杨贵妃传媒視頻 Health News: The Health of the Campaign
The 2024 presidential race is taking on a familiar tone 鈥 with Democrats accusing Republicans of wanting to ban abortion and repeal the Affordable Care Act and Republicans insisting they have no such plans. Voters will determine whom they believe. Meanwhile, for the second time in a month, a state judge overturned an abortion ban, but few expect the decision to settle the matter. Alice Miranda Ollstein of Politico, Sandhya Raman of CQ Roll Call, and Anna Edney of Bloomberg News join 杨贵妃传媒視頻 Health News chief Washington correspondent Julie Rovner to discuss these stories and more. Also this week, Rovner interviews 杨贵妃传媒視頻 Health News鈥 Lauren Sausser, who reported and wrote the latest 杨贵妃传媒視頻 Health News-Washington Post 鈥淏ill of the Month,鈥 about a teenage athlete whose needed surgery lacked a billing code.
Harris Correct That Trump Fell Short on Promise To Negotiate Medicare Drug Prices
The former president instead favored a temporary model that could鈥檝e brought down prices of some prescription drugs, but it was blocked by the courts.
California May Regulate and Restrict Pharmaceutical Brokers
California lawmakers are moving to rein in the pharmaceutical middlemen they say drive up costs and limit consumers鈥 choices. The bill sent to Gov. Gavin Newsom would require pharmacy benefit managers to be licensed in California and would ban some business practices. Newsom vetoed a previous effort three years ago.
With TV Drug Ads, What You See Is Not Necessarily What You Get
The pharmaceutical industry has invented a new art form: finding ways to make their wares seem like joyous must-have treatments, while often minimizing lackluster efficacy and risks.
En los comerciales de medicamentos en TV, lo que ves no siempre es lo que es
Los anuncios de medicamentos han sido omnipresentes en la televisi贸n desde finales de la d茅cada de 1990 y se han extendido a internet y las redes sociales. Pocas naciones en el mundo los permiten
For Pharma, Trump vs. Harris Is a Showdown Between Two Industry Foes
Vice President Kamala Harris is seen as more aggressive than former President Donald Trump in taking on pharmaceutical companies, but Trump allies say he would also make lowering drug costs a top priority.
Para las farmac茅uticas, la pelea entre Trump y Harris es entre dos enemigos de la industria
Legisladores de ambos partidos atacan cada vez m谩s a la industria, por los precios de los medicamentos que la mayor铆a de los estadounidenses consideran irrazonables.
How Little Denmark Got Homegrown Giant Novo Nordisk To Lower Ozempic Prices
As Congress pushes for Medicare to cover payment for anti-obesity drugs, Denmark 鈥 Ozempic maker Novo Nordisk鈥檚 home 鈥 has limited coverage of the drug after cost overruns 鈥渆mptied all the money boxes in the entire public health system.鈥
Copycat Weight-Loss Drugs Are Major Players With Consumers
As many as 1 in 8 American adults has tried one of the GLP-1 anti-obesity drugs, but a surprising number aren鈥檛 getting their supplies from pharma giants Novo Nordisk or Eli Lilly. Up to 30 percent of the market, by some estimates, is made up of copycat versions from compounding pharmacies. Compounding is legal, though […]
